Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Subscribe To Our Newsletter & Stay Updated
